PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19667110-5	2009	In the pravastatin group, the triallelic rs2032582 variant (G2677T/A) in ABCB1 was associated with the percent reduction in LDL-C (GG 23.3%, non-G heterozygote 20.3%, and non-G homozygote 17.4%, P=0.042).	Pravastatin	7-18	ATP binding cassette subfamily B member 1	Homo sapiens	73-78	
21820929-6	2012	RESULTS: CYP3A4 was responsible for the metabolism of lovastatin, simvastatin and atorvastatin; fluvastatin depends on CYP2C9; P-glycoprotein is responsible for decreased atorvastatin, pravastatin, simvastatin and lovastatin concentrations.	Pravastatin	185-196	ATP binding cassette subfamily B member 1	Homo sapiens	127-141	
19667110-7	2009	Polymorphisms in triallelic G2677T/A variant in ABCB1 were associated with the degree of LDL-C lowering with pravastatin.	Pravastatin	109-120	ATP binding cassette subfamily B member 1	Homo sapiens	48-53	
19694740-1	2009	AIMS: This study aimed to investigate possible effects of ABCB1 genotype on fluvastatin, pravastatin, lovastatin, and rosuvastatin pharmacokinetics.	Pravastatin	89-100	ATP binding cassette subfamily B member 1	Homo sapiens	58-63	
16722833-0	2006	Pharmacokinetics and response to pravastatin in paediatric patients with familial hypercholesterolaemia and in paediatric cardiac transplant recipients in relation to polymorphisms of the SLCO1B1 and ABCB1 genes.	Pravastatin	33-44	ATP binding cassette subfamily B member 1	Homo sapiens	200-205	
16722833-1	2006	AIMS: Our aim was to investigate associations between the single nucleotide polymorphisms (SNPs) in the SLCO1B1 (encoding OATP1B1) and ABCB1 (encoding P-glycoprotein) genes with the pharmacokinetics and efficacy of pravastatin in children with heterozygous familial hypercholesterolaemia (HeFH) and in paediatric cardiac transplant recipients.	Pravastatin	215-226	ATP binding cassette subfamily B member 1	Homo sapiens	135-140	
17923246-11	2007	Addition of a HMG-CoA reductase inhibitor to KG1a cells resulted in an additional 26% (lovastatin, p = 0.03) and 16% (pravastatin, p = 0.05) reduction in pgp, respectively.	Pravastatin	118-129	ATP binding cassette subfamily B member 1	Homo sapiens	154-157